2-chloro-n(6)cyclopentyladenosine and atenolol

2-chloro-n(6)cyclopentyladenosine has been researched along with atenolol in 1 studies

Compound Research Comparison

Studies (2-chloro-n(6)cyclopentyladenosine)	Trials (2-chloro-n(6)cyclopentyladenosine)	Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine)	Studies (atenolol)	Trials (atenolol)	Recent Studies (post-2010) (atenolol)
252	0	43	5,473	1,950	852

Protein Interaction Comparison

Protein	Taxonomy	atenolol (IC50)
Beta-1 adrenergic receptor	Homo sapiens (human)	0.7468
Alpha-1D adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1A adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1B adrenergic receptor	Homo sapiens (human)	0.23

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casati, C; Forlani, A; Lozza, G; Monopoli, A	1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and atenolol

Article	Year
Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit. Pharmacological research, 1997, Volume: 35, Issue:1 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents	1997

Article

Year

Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.

Pharmacological research, 1997, Volume: 35, Issue:1

Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents

1997